A paper by Westrich et al. (2023) examines payer perceptions of 5 completely different worth frameworks. Value frameworks of curiosity included:
- American Society of Clinical Oncology (ASCO) Value Framework,
- Drug Pricing Lab’s Drug Abacus (previously Memorial Sloan Kettering Cancer Center’s Drug Abacus),
- Institute for Clinical and Economic Review (ICER) worth evaluation framework and proof studies
- The Innovation and Value Initiative (IVI)’s Open-Source Value Project fashions,
- National Comprehensive Cancer Network (NCCN)’s Evidence Blocks
The authors carried out a double-blind, web-based survey to evaluate payers’ perceptions of those worth frameworks. Overall, 51 well being care payer respondents discovered that the crucial components when choosing a worth framework was that (i) acceptable metrics and outcomes had been included, (ii) comparative scientific effectiveness data was supplied and (iii) the outcomes had been methodologically rigorous and unbiased.
Among the 5 worth frameworks, ICER, NCCN and ASCO had been the worth frameworks thought-about most helpful for formulary choices, whereas ICER was far and away probably the most helpful for drug value negotiations.
